Sarepta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. 

CEO
Douglas S. Ingram
CEODouglas S. Ingram
Employees
835
Employees835
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1980
Founded1980
Employees
835
Employees835

SRPT Key Statistics

Market cap
1.72B
Market cap1.72B
Price-Earnings ratio
-1.94
Price-Earnings ratio-1.94
Dividend yield
Dividend yield
Average volume
2.58M
Average volume2.58M
High today
$17.59
High today$17.59
Low today
$16.30
Low today$16.30
Open price
$17.47
Open price$17.47
Volume
2.29M
Volume2.29M
52 Week high
$103.32
52 Week high$103.32
52 Week low
$10.42
52 Week low$10.42

Stock Snapshot

As of today, Sarepta Therapeutics(SRPT) shares are valued at $16.40. The company's market cap stands at 1.72B, with a P/E ratio of -1.94.

During the trading session on 2026-03-15, Sarepta Therapeutics(SRPT) shares reached a daily high of $17.59 and a low of $16.30. At a current price of $16.40, the stock is +0.6% higher than the low and still -6.8% under the high.

Trading volume for Sarepta Therapeutics(SRPT) stock has reached 2.29M, versus its average volume of 2.58M.

The stock's 52-week range extends from a low of $10.42 to a high of $103.32.

The stock's 52-week range extends from a low of $10.42 to a high of $103.32.

SRPT News

TipRanks 1d
Carvana, Warner Bros, Axon, Energy Fuels, Sarepta Insider Shakeup

Insiders have been trading these 5 stocks: ((CVNA)), ((WBD)), ((AXON)), ((UUUU)) and ((SRPT)). Here is a breakdown of their recent trades and their value. Dire...

TipRanks 2d
Sarepta price target raised to $31 from $26 at Mizuho

Mizuho raised the firm’s price target on Sarepta (SRPT) to $31 from $26 and keeps an Outperform rating on the shares. The firm updated the company’s model to in...

Analyst ratings

52%

of 25 ratings
Buy
28%
Hold
52%
Sell
20%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.